Merkury S.A.
Sejneńska 16, 15-399 Białystok
TAX ID5423228109
Phone+48691335321
Rate company:
Merkury S.A.
TAX ID5423228109
KRS0000438106
Share capital100,000.00 zł
Not confirmed
address
Sejneńska 16, 15-399 Białystok
Phone number
+48691335321Website
http://www.merkurysa.plCategories
Main category
About us
This text has been translated automaticallyThe pharmaceutical wholesaler MERKURY has been on the market since January 2004. Thanks to our work and many years of experience, we have become a leader in the field of professional consultancy and distribution of parapharmaceuticals. By using our logistics capabilities, we also offer FMCG products. In 2012, we transformed from a general partnership into a joint-stock company with the share capital of PLN 2 735 800.00 paid in full.
Activity type
wholesaler, distributorRegister Data
NIP
5423228109 
REGON
200740280
KRS
0000438106
Legal form
joint stock company
ALEO.com Registration Date
2016-07-29
Register Address
UL. SEJNEŃSKA 16, 15-399 BIAŁYSTOK
Date of registration in KRS
2012-10-29
Date of commencement of economic activity
2012-10-29
Act signature
BI.XII NS-REJ.KRS/2644/25/653
Website
http://www.merkurysa.pl
Pkd codes
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.21.Z - Wholesale trade of cereals, unprocessed tobacco, seeds, and animal feed
46.34.B - Wholesale trade of non-alcoholic beverages
46.36.Z - Wholesale trade of sugar, chocolate, and confectionery
46.37.Z - Wholesale trade of tea, coffee, cocoa, and spices
46.38.Z - Wholesale trade of other food products
46.43.Z - Wholesale trade of electrical household goods
46.44.Z - Wholesale trade of porcelain, ceramic, and glass products, as well as cleaning products
46.45.Z - Wholesale trade of perfumes and cosmetics
77.11.Z - Rental and leasing of passenger cars and light motor vehicles
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 5,5 | 4,8 | 7,9 | 65,2 |
EBITDA | 9,8 | 10,9 | 17,4 | 59,5 |
Short time liabilities | 67,8 | 57,5 | 66,2 | 15,2 |
Equity capital | 35,5 | 37,1 | 40,6 | 9,4 |
Operating profit (EBIT) | 6,3 | 7,1 | 13,2 | 85,8 |
Assets | 114,3 | 103 | 112,4 | 9,1 |
Net profit (loss) | 4,5 | 3,5 | 5,4 | 53,5 |
Cash | 0,1 | 0,4 | 0,3 | -13,5 |
Net income from sale | 274,7 | 306,3 | 333,7 | 9 |
Liabilities and provisions for liabilities | 78,8 | 65,9 | 71,8 | 8,9 |
Working assets | 95,2 | 86,6 | 94,8 | 9,5 |
Depreciation | 3,5 | 3,8 | 4,2 | 10,2 |
% | % | % | p.p. | |
Profitability of capital | 12,8 | 9,4 | 13,2 | 3,8 |
Equity capital to total assets | 31,1 | 36 | 36,1 | 0,1 |
Gross profit margin | 2 | 1,6 | 2,4 | 0,8 |
EBITDA Margin | 3,6 | 3,6 | 5,2 | 1,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 90 | 69 | 72 | 3 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the consolidated annual financial statements of the capital group
Download pdf01-01-2023 - 31-12-2023
A report on the activities of the parent company and a report on the activities of the capital group
Download pdf01-01-2023 - 31-12-2023
Consolidated annual financial statements
Download xml01-01-2023 - 31-12-2023
Consolidated annual financial statements
Download pdf01-01-2023 - 31-12-2023
A resolution or a decision approving the consolidated annual financial statements
Download pdf01-01-2023 - 31-12-2023
Consolidated annual financial statements
Download xml01-01-2023 - 31-12-2023
Consolidated annual financial statements
Download pdf01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the consolidated annual financial statements of the capital group
Download pdf01-01-2023 - 31-12-2023
A report on the activities of the parent company and a report on the activities of the capital group
Download pdfShow more (12)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
VITAMIN CLINIC WROCŁAW
Wrocław
ZIELARNIA MELANIE HERBS MAGDALENA IVKOVIĆ
Strzelce Klasztorne
Wamed-Lab sp. z o.o.
Warszawa
Hi-Tech Medical
Warszawa
ELŻBIETA STĘPNIAK
Szczecin
Bioevolution sp. z o.o. sp.k.
Warszawa
OPTICAL WOJCIECH SKAWSKI
MYŚLENICE
Przedsiębiorstwo Trans-Med
Zawiercie